Evidence map›Paper›PMID 26337967›Full record

ReviewInternal and emergency medicine2015

The internist and the renal resistive index: truths and doubts.

Maria Boddi, Fabrizia Natucci, Elisa Ciani

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Internal and emergency medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03958851 (Measurement of Renal Artery Resistive Index as a Predictor of Severity of Lupus Nephritis and Its Response to Treatment), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03958851 unknown statusnot on this mapstarted 2019, after this paper: background citation

Measurement of Renal Artery Resistive Index as a Predictor of Severity of Lupus Nephritis and Its Response to Treatment

TypeobservationalSponsorAssiut UniversityRan2019 to 2022Enrolled120ConditionsLupus NephritisArmsDoppler ultrasonography of renal arteries, Renal biopsy, kidney function tests, The 24-hour urine protein test, complete blood counting (CBC)
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. What is new in hemodynamic monitoring and management?Journal of clinical monitoring and computing · 2022
    Review
  12. Article
  13. Evaluation of Intra-Renal Stiffness in Patients with Primary Aldosteronism.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2022
    Article
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maria BoddiDepartment of Experimental and Clinical Medicine, University of Florence, Viale Morgagni 85, 50134, Florence, Italy. maria.boddi@unifi.it.
Fabrizia NatucciDepartment of Experimental and Clinical Medicine, University of Florence, Viale Morgagni 85, 50134, Florence, Italy. fabrizia.natucci@gmail.com.
Elisa CianiDepartment of Experimental and Clinical Medicine, University of Florence, Viale Morgagni 85, 50134, Florence, Italy.
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The renal resistive index (RRI) is measured by Doppler sonography in an intrarenal artery, and is the difference between the peak systolic and end-diastolic blood velocities divided by the peak systolic velocity. The RRI is used for the study of vascular and renal parenchymal renal abnormalities, but growing evidence indicates that it is also a dynamic marker of systemic vascular properties. Renal vascular resistance is only one of several renal (vascular compliance, interstitial and venous pressure), and extrarenal (heart rate, aortic stiffness, pulse pressure) determinants that combine to determine the RRI values, and not the most important one. RRI cannot always be considered a specific marker of renal disease. To summarize from the literature: (1) hydronephrosis, abdominal hypertension, renal vein thrombosis and acute kidney injury are all associated with an acute increase in interstitial and venous pressure that determine RRI values. In all these conditions, RRI is a reliable marker of the severity of renal damage. (2) The hemodynamic impact of renal artery stenosis can be assayed by the RRI decrease in the homolateral kidney by virtue of decreasing pulse pressure. However, renal diseases that often coexist, increase renal vascular stiffness and hide the hemodynamic effect of renal stenosis. (3) In transplant kidney and in chronic renal disease, high RRI values (>0.80) can independently predict renal and clinical outcomes, but systemic (pulse pressure) rather than renal hemodynamic determinants sustain the predictive role of RRI. (4) Higher RRI detects target renal organ damage in hypertension and diabetes when renal function is still preserved, as a marker of systemic atherosclerotic burden. Is this the fact? We attempt to answer.

Indexed as

Blood Flow VelocityBlood PressureHeart RateHumansKidneyKidney DiseasesRenal ArteryUltrasonography, DopplerVascular ResistanceVascular StiffnessArterial stiffnessPulse pressureRenal diseaseRenal resistive indexUltrasound

Identifiers

PMID26337967
OpenAlexW2179304282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.